BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver Data on hepatic histopathological findings in COVID-19 is scarce AIM: To characterize hepatic pathological findings in patients with COVID-19 METHODS: We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed Articles including less than ten patients were excluded Proportions were pooled using random-effects models Q statistic and I2 were used to assess heterogeneity and levels of evidence, respectively RESULTS: We identified 18 studies from 7 countries;all were case reports and case series from autopsies All the patients were over 15 years old, and 67 2% were male We performed a meta-analysis of 5 studies, including 116 patients Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55 1% [95% confidence interval (CI): 46 2-63 8], congestion of hepatic sinuses 34 7% (95%CI: 7 9-68 4), vascular thrombosis 29 4% (95%CI: 0 4-87 2), fibrosis 20 5% (95%CI: 0 6-57 9), Kupffer cell hyperplasia 13 5% (95%CI: 0 6-54 3), portal inflammation 13 2% (95%CI: 0 1-48 8), and lobular inflammation 11 6% (95%CI: 0 3-35 7) We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis CONCLUSION: We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation Further studies are needed to establish the mechanisms and implications of these findings
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: a systematic review and meta-analysis of autopsy data